To date only two approaches have been accepted in the prognosis of MM: the International Staging System (ISS), which combines albumin and β2-microglobulin levels, and the presence of chromosomal abnormalities detected via FISH (fluorescence in situ hybridization) [6,33]. This evidence concerns the gene HLA-G and Miyoshi myopathy.